Stock comparison
Mycronic AB (publ)
MYCR.ST$67.76BIndustrials Market cap, Sector
Everpure
P$24.7BIndustrials Market cap, Sector
Overall winner
Mycronic AB (publ)
MYCR.ST 70 P
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
MYCR.ST7wins
0winsP
77B
D46
85A
C60
85A
D53
69C
F39
66C
F4
78B
F39
77B
F40
Side-by-side metrics
| Metric | MYCR.ST | P |
|---|---|---|
| Market cap | Winner: $67.76B | $24.7B |
| P/E (TTM) | Winner: 37.5x | 139.6x |
| EV/EBIT | Winner: 29.1x | 224.5x |
| ROIC (TTM) | Winner: 20.79% | 3.43% |
| Gross margin | 52.44% | 70.38% Winner |
| Net margin | Winner: 19.65% | 5.14% |
| Revenue CAGR 5y | Winner: 15.75% | 13.84% |
| EPS CAGR 5y | 28.15% | - |
| Debt / Equity | Winner: 0.0x | 0.1x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MYCR.ST leads on
- EV/EBIT29.1xvs 224.5x+87%
- ROIC (TTM)20.79%vs 3.43%+83%
- Net margin19.65%vs 5.14%+74%
- P/E (TTM)37.5xvs 139.6x+73%
P leads on
- Gross margin70.38%vs 52.44%+25%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.